- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
Exhibit 10.2
8001 Arista Place, Suite 430
Broomfield, CO 80021
Phone: 720-940-2200, Fax: 720-208-9261
July 26, 2013
Richard Clark
Senior Marketing Director
Medtronic, Inc.
8200 Coral Sea Street NE
Mounds View, MN 55112
RE: Clinical Trial Collaboration Agreement dated April 18, 2013 between ARCA biopharma, Inc., and Medtronic, Inc.
Dear Richard:
When countersigned by Medtronic, this letter shall serve as a permanent waiver of Medtronic’s rights under Section 8.2 (f), and ARCA’s rights under Section 8.3 (e) of the above-referenced Agreement.
| Very truly yours, |
|
|
| /s/ Christopher D. Ozeroff |
| Christopher D. Ozeroff |
Accepted andAgreed this____31st____ day ofJuly, 2013:
|
|
|
Medtronic, Inc. |
| |
|
|
|
|
|
|
By: | /s/ Richard Clark |
|
|
|
|
|
|
|
Its: | Senior Marketing Director |
|